These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Incidence and Risk Factors of Pulmonary Hypertension After Venous Thromboembolism: An Analysis of a Large Health Care Database. Lutsey PL; Evensen LH; Thenappan T; Prins KW; Walker RF; Farley JF; MacLehose RF; Alonso A; Zakai NA J Am Heart Assoc; 2022 Jul; 11(14):e024358. PubMed ID: 35861839 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Holst AG; Jensen G; Prescott E Circulation; 2010 May; 121(17):1896-903. PubMed ID: 20404252 [TBL] [Abstract][Full Text] [Related]
5. The Risk of Venous Thromboembolism in Patients with Gallstones. Chen CH; Lin CL; Kao CH Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32340378 [TBL] [Abstract][Full Text] [Related]
6. Orthostatic Hypotension and Risk of Venous Thromboembolism in 2 Cohort Studies. Bell EJ; Agarwal SK; Cushman M; Heckbert SR; Lutsey PL; Folsom AR Am J Hypertens; 2016 May; 29(5):634-40. PubMed ID: 26306405 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study. Cohen AT; Katholing A; Rietbrock S; Bamber L; Martinez C Thromb Haemost; 2017 Jan; 117(1):57-65. PubMed ID: 27709226 [TBL] [Abstract][Full Text] [Related]
8. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study. Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA; PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386 [TBL] [Abstract][Full Text] [Related]
9. American Heart Association's Life's Simple 7 and risk of venous thromboembolism: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Olson NC; Cushman M; Judd SE; McClure LA; Lakoski SG; Folsom AR; Safford MM; Zakai NA J Am Heart Assoc; 2015 Feb; 4(3):e001494. PubMed ID: 25725088 [TBL] [Abstract][Full Text] [Related]
10. Risk of venous thromboembolism in knee, hip and hand osteoarthritis: a general population-based cohort study. Zeng C; Bennell K; Yang Z; Nguyen UDT; Lu N; Wei J; Lei G; Zhang Y Ann Rheum Dis; 2020 Dec; 79(12):1616-1624. PubMed ID: 32938637 [TBL] [Abstract][Full Text] [Related]
11. The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort. Gade IL; Braekkan SK; Naess IA; Hansen JB; Cannegieter SC; Overvad K; Jensvoll H; Hammerstrøm J; Blix K; Tjønneland A; Kristensen SR; Severinsen MT J Thromb Haemost; 2017 Aug; 15(8):1567-1575. PubMed ID: 28585779 [TBL] [Abstract][Full Text] [Related]
12. Risk of venous thromboembolism in patients with rheumatoid arthritis. Kim SC; Schneeweiss S; Liu J; Solomon DH Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1600-7. PubMed ID: 23666917 [TBL] [Abstract][Full Text] [Related]
13. Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419 [TBL] [Abstract][Full Text] [Related]
14. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Tagalakis V; Patenaude V; Kahn SR; Suissa S Am J Med; 2013 Sep; 126(9):832.e13-21. PubMed ID: 23830539 [TBL] [Abstract][Full Text] [Related]
15. Risk and complications of venous thromboembolism in dialysis patients. Molnar AO; Bota SE; McArthur E; Lam NN; Garg AX; Wald R; Zimmerman D; Sood MM Nephrol Dial Transplant; 2018 May; 33(5):874-880. PubMed ID: 28992258 [TBL] [Abstract][Full Text] [Related]
16. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease. Goto S; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Weitz JI; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat A; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK; JAMA Netw Open; 2020 Oct; 3(10):e2022886. PubMed ID: 33112399 [TBL] [Abstract][Full Text] [Related]
17. Risk of recurrent venous thromboembolism among deep vein thrombosis and pulmonary embolism patients treated with warfarin. Nordstrom BL; Evans MA; Murphy BR; Nutescu EA; Schein JR; Bookhart BK Curr Med Res Opin; 2015 Mar; 31(3):439-47. PubMed ID: 25495136 [TBL] [Abstract][Full Text] [Related]
18. Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis. Wattanakit K; Lutsey PL; Bell EJ; Gornik H; Cushman M; Heckbert SR; Rosamond WD; Folsom AR Thromb Haemost; 2012 Sep; 108(3):508-15. PubMed ID: 22782466 [TBL] [Abstract][Full Text] [Related]
19. Trends of venous thromboembolism risk before and after diagnosis of gout: a general population-based study. Li L; McCormick N; Sayre EC; Esdaile JM; Lacaille D; Xie H; Choi HK; Aviña-Zubieta JA Rheumatology (Oxford); 2020 May; 59(5):1099-1107. PubMed ID: 31535692 [TBL] [Abstract][Full Text] [Related]
20. High incidence of venous thromboembolism recurrence in patients with sickle cell disease. Brunson A; Keegan T; Mahajan A; White R; Wun T Am J Hematol; 2019 Aug; 94(8):862-870. PubMed ID: 31074115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]